Price data is not available
Insight Molecular Diagnostics Inc
IMDXNASDAQ
Insight Molecular (IMDX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.23 | $-0.26 | $-0.24 | $-0.24 |
| Actual | $-0.23 | $-0.28 | $-0.27 | $-0.34 |
| Surprise | 0.00% | -7.69% | -12.5% | -41.7% |
| Revenue | ||||
| Estimate | $437500 | $227500 | $285000 | $285000 |
| Actual | $239000 | $32000 | $1.1M | $139000 |
| Surprise | -45.4% | -85.9% | +299.7% | -51.2% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.22 | $-0.23 |
| Revenue | ||
| Consensus | $244280 | $473720 |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $-0.23 | $-0.23 | 0.00 % |
| Q1 | May 13, 2026 | $-0.28 | $-0.26 | -7.69 % |
| Q4 | Mar 26, 2026 | $-0.27 | $-0.24 | -12.5 % |
| Q3 | Nov 10, 2025 | $-0.34 | $-0.24 | -41.7 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $239.00K | $437.50K | -45.4 % |
| Q1 | May 13, 2026 | $32.00K | $227.50K | -85.9 % |
| Q4 | Mar 26, 2026 | $1.14M | $285.00K | 299.7 % |
| Q3 | Nov 10, 2025 | $139.00K | $285.00K | -51.2 % |
